Atlas Trials

Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder

Clinical trial NCT03078075 · COMPLETED

Trial details

NCT number
NCT03078075
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Methamphetamine Use Disorder
Start date
2017-05-05
Primary completion
2019-07-03
Enrollment
403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.